Nuo Therapeutics, Inc. (AURX)
OTCMKTS
· Delayed Price · Currency is USD
2.260
0.00 (0.00%)
At close: Dec 5, 2025
Nuo Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2.61 | 1.37 | 0.61 | 0.11 | - | - | Upgrade
|
| Revenue Growth (YoY) | 123.72% | 124.34% | 442.12% | - | - | - | Upgrade
|
| Cost of Revenue | 0.77 | 0.3 | 0.13 | 0.02 | - | - | Upgrade
|
| Gross Profit | 1.84 | 1.06 | 0.48 | 0.09 | - | - | Upgrade
|
| Selling, General & Admin | 4.4 | 3.52 | 3.65 | 3.41 | 0.09 | 0.38 | Upgrade
|
| Operating Expenses | 4.4 | 3.52 | 3.65 | 3.41 | 0.09 | 0.38 | Upgrade
|
| Operating Income | -2.57 | -2.46 | -3.17 | -3.32 | -0.09 | -0.38 | Upgrade
|
| Interest Expense | -0 | - | -0 | -0 | - | -0.05 | Upgrade
|
| Interest & Investment Income | - | 0 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0 | 0 | - | 0 | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -2.56 | -2.46 | -3.17 | -3.32 | -0.09 | -0.43 | Upgrade
|
| Other Unusual Items | 0.13 | 0.13 | - | 0.15 | - | 0.34 | Upgrade
|
| Pretax Income | -2.43 | -2.32 | -3.17 | -3.17 | -0.09 | -0.09 | Upgrade
|
| Net Income | -2.43 | -2.32 | -3.17 | -3.17 | -0.09 | -0.09 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.8 | -7.8 | Upgrade
|
| Net Income to Common | -2.43 | -2.32 | -3.17 | -3.17 | -0.89 | 7.71 | Upgrade
|
| Shares Outstanding (Basic) | 47 | 45 | 42 | 40 | 30 | 26 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 45 | 42 | 40 | 30 | 27 | Upgrade
|
| Shares Change (YoY) | 6.37% | 7.95% | 5.19% | 32.03% | 10.93% | 15.13% | Upgrade
|
| EPS (Basic) | -0.05 | -0.05 | -0.08 | -0.08 | -0.03 | 0.30 | Upgrade
|
| EPS (Diluted) | -0.05 | -0.05 | -0.08 | -0.08 | -0.03 | 0.27 | Upgrade
|
| Free Cash Flow | -1.16 | -2.39 | -3.18 | -3.77 | -0.12 | -0.05 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.05 | -0.07 | -0.09 | -0.00 | -0.00 | Upgrade
|
| Gross Margin | 70.38% | 77.82% | 79.28% | 82.88% | - | - | Upgrade
|
| Operating Margin | -98.28% | -180.04% | -520.65% | -2958.21% | - | - | Upgrade
|
| Profit Margin | -93.06% | -170.21% | -521.17% | -2825.60% | - | - | Upgrade
|
| Free Cash Flow Margin | -44.59% | -174.82% | -521.76% | -3355.12% | - | - | Upgrade
|
| EBITDA | -2.49 | -2.43 | -3.15 | -3.31 | - | -0.29 | Upgrade
|
| EBITDA Margin | -95.48% | -178.35% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.07 | 0.02 | 0.02 | 0.01 | - | 0.09 | Upgrade
|
| EBIT | -2.57 | -2.46 | -3.17 | -3.32 | -0.09 | -0.38 | Upgrade
|
| EBIT Margin | -98.28% | -180.04% | - | - | - | - | Upgrade
|
| Revenue as Reported | 2.61 | 1.37 | 0.61 | 0.11 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.